首页> 外国专利> ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM

ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM

机译:血管生成调节增强梗死心肌成纤维细胞的心肌细胞重编程

摘要

Provided is a method of treating coronary artery disease in a mammal, comprising administering to a region of the heart of the mammal (a) a first vector encoding one or more angiogenic proteins which induce vascularization in the heart of the mammal, and (b) a second vector encoding one or more cardio-differentiating transcription factors which induce the production of induced cardiomyocytes (iCM) in the heart of the mammal, whereby the coronary artery disease in the mammal is treated. In a preferred embodiment, the first vector is an adenoviral vector encoding VEGF and the second vector is a lentiviral vector encoding Gata4, Mef2c, and Tbx5 (GMT).
机译:本发明提供了一种治疗哺乳动物冠状动脉疾病的方法,包括向哺乳动物心脏的一个区域投与(a)第一载体,该第一载体编码一种或多种血管生成蛋白,其诱导哺乳动物心脏中的血管生成,和(b)编码一个或多个心脏分化转录因子的第二载体,其诱导哺乳动物心脏中诱导心肌细胞(iCM)的产生,由此治疗哺乳动物中的冠状动脉疾病。在优选实施例中,第一载体是编码VEGF的腺病毒载体,第二载体是编码Gata4、Mef2c和Tbx5(GMT)的慢病毒载体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号